CTIC is making big moves today. Find out why the stock is trading 7% higher:

Shares of Cti Biopharm Corp (CTIC) are trading 7% higher at a price of $5.765 at the time of this writing. The stock is quickly surpassing peers on a meh day for the Health Care sector.

The share price is likely moving as a result of the recent earnings call on August 11, where the company showed an increased in booked revenue, beating analyst estimates. Analysts have set a higher price target for the stock as well.

Cti Biopharm Corp has been trading between a 52-week high of $7.8 and a 52-week low of $1.43. The stock has a market cap of $659 Million.

CTI BioPharma Corp. is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. The company concentrates its efforts on treatments that target blood-related cancers where there is an unmet medical need.